Speaker illustration

Doctor Ipek Aydin

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

Member of:

Heart Failure Association of the ESC

Dr. İpek Aydın is a cardiology resident at Istanbul University-Cerrahpaşa, Institute of Cardiology where she started her training in June 2022. She is an early-career investigator with a strong focus on acute and chronic heart failure.Her research integrates clinical data, biomarkers and multimodality cardiovascular imaging to better understand prognosis and therapeutic response across the heart failure spectrum. She is actively involved in heart failure registries and prospective clinical research, aiming to bridge advanced imaging and precision medicine with everyday clinical practice.Dr. Aydın regularly presents her work at international scientific congresses and contributes to peer-reviewed publications. She is committed to advancing collaborative research within the heart failure community and fostering innovation in patient-centered care.She is a member of the European Society of Cardiology and the Turkish Society of Cardiology, and she speaks Turkish and English.

Advanced pulmonary regurgitation and left ventricular non-compaction coexistence in an adult with repaired tetralogy of fallot

Event: Heart Failure 2025

Topic: Clinical

Session: A focus on non-compaction and takotsubo

Thumbnail

Galectin-3 as a biomarker to predict cardiorenal syndrome in patients with acute heart failure

Event: Heart Failure 2025

Topic: Biomarkers

Session: Novel blood biomarkers in heart failure

Thumbnail

Unmasking AL(ligth chain) amyloidosis in a patient with heart failure and syncope: a comprehensive diagnostic journey

Event: Heart Failure 2025

Topic: Clinical

Session: Amyloidosis - it never comes alone?

Thumbnail

Unraveling the genetic tapestry of dilated cardiomyopathy: a case involving CD36 and TNXB mutations

Event: Heart Failure 2025

Topic: Clinical

Session: It’s all about genetics

Thumbnail

6p.R220L is a pathogenic novel GLA gene mutation responsible for a cardiac phenotype of Fabry disease

Event: Heart Failure 2024

Topic: Clinical

Session: Cardiomyopathies - imaging in the hypertrophied heart

Thumbnail

ESC 365 is supported by